The 14th Asian Congress on Endometriosis (ACE 2026) takes place on 23–25 October 2026 at the Pan Pacific Singapore, under the theme "Changing the Narrative: A New Dawn for Endometriosis and Adenomyosis."
About the congress
ACE 2026 brings regional and international experts to Singapore for a key meeting on the understanding and management of endometriosis and adenomyosis. The congress highlights emerging science, evolving diagnostic pathways and new clinical strategies that are changing care across the disease spectrum.
Scientific programme
The programme covers:
- Translational research — pathogenesis, biomarkers and new therapeutic targets
- Advanced imaging — ultrasound and MRI mapping for non-invasive diagnosis
- Complex surgery — deep endometriosis, bowel and urinary tract disease, and adenomyosis-sparing surgery
- Fertility preservation and assisted reproduction in endometriosis
- Medical therapy and long-term management
- Pain science and multidisciplinary, patient-centred care
Pre-congress workshops complement the main sessions, and the website lists the faculty, the organising committee and the scientific programme.
Key dates
- Abstract submission deadline: 15 September 2026 (now closed)
- Early-bird registration deadline: 30 September 2026
- Congress: 23–25 October 2026
Who should attend
Gynaecologists, reproductive endocrinologists and fertility specialists, minimally invasive gynaecologic surgeons, radiologists, pain specialists, colorectal and urological surgeons, nurses, researchers and trainees from across Asia and beyond.
Why attend
ACE is the main Asian forum dedicated to endometriosis. It offers world-class speakers, the latest research, networking with peers and a chance to help redefine standards of care in a condition that affects about one in ten women of reproductive age.
Registration, hotel reservations, visa and travel information and sponsor details are on the official website. CME credits and fees are to be confirmed there.
